Induction of Heme Oxygenase-1 Can Halt and Even Reverse Renal Tubule-Interstitial Fibrosis

Background: The tubule-interstitial fibrosis is the hallmark of progressive renal disease and is strongly associated with inflammation of this compartment. Heme-oxygenase-1 (HO-1) is a cytoprotective molecule that has been shown to be beneficial in various models of renal injury. However, the role of HO-1 in reversing an established renal scar has not yet been addressed. Aim: We explored the ability of HO-1 to halt and reverse the establishment of fibrosis in an experimental model of chronic renal disease. Methods: Sprague-Dawley male rats were subjected to unilateral ureteral obstruction (UUO) and divided into two groups: non-treated and Hemin-treated. To study the prevention of fibrosis, animals were pre-treated with Hemin at days -2 and -1 prior to UUO. To investigate whether HO-1 could reverse established fibrosis, Hemin therapy was given at days 6 and 7 post-surgery. After 7 and/or 14 days, animals were sacrificed and blood, urine and kidney tissue samples were collected for analyses. Renal function was determined by assessing the serum creatinine, inulin clearance, proteinuria/creatininuria ratio and extent of albuminuria. Arterial blood pressure was measured and fibrosis was quantified by Picrosirius staining. Gene and protein expression of pro-inflammatory and pro-fibrotic molecules, as well as HO-1 were performed. Results: Pre-treatment with Hemin upregulated HO-1 expression and significantly reduced proteinuria, albuminuria, inflammation and pro-fibrotic protein and gene expressions in animals subjected to UUO. Interestingly, the delayed treatment with Hemin was also able to reduce renal dysfunction and to decrease the expression of pro-inflammatory molecules, all in association with significantly reduced levels of fibrosis-related molecules and collagen deposition. Finally, TGF-beta protein production was significantly lower in Hemin-treated animals. Conclusion: Treatment with Hemin was able both to prevent the progression of fibrosis and to reverse an established renal scar. Modulation of inflammation appears to be the major mechanism behind HO-1 cytoprotection.Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP[07/07139-3]Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPESInstituto Nacional de Ciencia e Tecnologia de Complexos Fluidos (INCT)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNP

Dispositivo fotobiomodulador para prevenção e tratamento de hiperqueratose de teto em vacas leiteiras

As mastites estão entre as principais causas de prejuízo para produtores de leite. Em casos graves de hiperqueratose, o canal do teto pode se tornar uma barreira mais fácil para que as bactérias penetrem na glândula mamária. Os objetivos deste estudo foram avaliar um dispositivo fotobiomodulador de LED para tratamento e prevenção de hiperqueratose de teto e prevenção da mastite subclínica em um rebanho de leite com alta prevalência de hiperqueratose (35,3% de casos graves). Foram utilizadas 60 primíparas para o experimento de prevenção e 30 vacas com hiperqueratose para o experimento terapêutico. Em ambos os experimentos, metade dos animais foram tratados com o dispositivo fotobiomodulador três vezes por semana, durante 6 semanas. Os outros animais foram os controles. Imagens fotográficas digitalizadas foram realizadas na avaliação inicial e, semanalmente, por 6 semanas consecutivas. Nas primíparas, novas avaliações foram realizadas entre 6 e 7 meses de lactação. Para avaliação da mastite subclínica, contagem de células somáticas (CCS) foram feitas mensalmente. No experimento preventivo, o diâmetro externo das lesões permaneceu constante nos tetos do grupo tratado, enquanto houve aumento no grupo controle. No experimento terapêutico não foram observadas diferenças estatísticas entre as variáveis de hiperqueratose. Contudo, o grupo tratado apresentou menor incidência de mastites subclínicas (CCS < 250 células/mL) por lactação do que o grupo controle (P<0,05). Em conclusão, o tratamento não foi efetivo em prevenir o desenvolvimento ou reduzir lesões instaladas de hiperqueratose de teto. Contudo, o uso protótipo se mostrou útil e promissor como adjuvante na prevenção do aumento de tamanho das lesões de hiperqueratose de teto em primíparas e como forma de reduzir incidência de mastite subclínicas em vacas leiteiras já acometidas

Apoptose no cólon menor eqüino submetido à isquemia e reperfusão experimentais Apoptosis in equine small colon subjected to experimental ischemia and reperfusion

Isquemia e reperfusão intestinais são importantes fatores de mortalidade em eqüinos. O objetivo deste estudo foi detectar e quantificar a apoptose na mucosa do cólon menor eqüino em um modelo de isquemia e reperfusão. Realizou-se a exposição cirúrgica do cólon menor de doze eqüinos e demarcaram-se dois segmentos intestinais que foram submetidos a 90 (SI) ou 180 (SII) minutos de isquemia arteriovenosa completa. Foram coletadas amostras intestinais antes da isquemia (controle), ao seu final e após 90 e 180 minutos de reperfusão. As amostras foram processadas histologicamente e coradas pela Hematoxilina e Eosina (SI e SII) e pela técnica de TUNEL (SII). Foram digitalizadas imagens histológicas e procedeu-se análise morfométrica para detectar ocorrência de apoptose e determinar o índice apoptótico (IA). Após 90 ou 180 minutos de isquemia arteriovenosa, verificou-se um aumento do IA comparado ao controle, embora não tenha sido detectada diferença entre os diferentes períodos de isquemia (PIntestinal ischemia and reperfusion are important factors for mortality in horses. The objective of this study was to detect and to quantify apoptosis in the mucosa of equine small colon in a model of ischemia and reperfusion. The small colon was surgically exposed in twelve horses, and two intestinal segments were demarcated and subjected to 90 (SI) or 180 (SII) minutes of complete arteriovenous ischemia. Intestinal samples were collected before ischemia (control), at its end and after 90 and 180 minutes of reperfusion. Samples were histological processed and stained by hematoxylin and eosin (SI and SII) and by the technique of TUNEL (SI). Digitized histological images were analyzed morphometrically to detect apoptotic cells and to determine the apoptotic index (AI). After 90 or 180 minutes of arteriovenous ischemia, an increase in apoptotic cells was verified when compared with the control group, although no difference could be detected between the different periods of ischemia (P<0.05). After the first 90 minutes of reperfusion, a decrease in AI occurred, similar in both segments, possibly due to lack of energy source promoted by ischemia. AI was maximized after 180 minutes of reperfusion (sample harvested only in SI) (P<0.05). In conclusion, apoptosis is an important cause of cellular mucosal death in equine small colon ischemic obstruction, occurring early in ischemia, and later (after 90 minutes) in the reperfusion period